RATS IMMUNIZED WITH CHOLINERGIC SYNAPTOSOMES - A MODEL FOR LAMBERT-EATON SYNDROME

被引:5
|
作者
CHAPMAN, J
RABINOWITZ, R
KORCZYN, AD
MICHAELSON, DM
机构
[1] TEL AVIV UNIV,SACKLER SCH MED,DEPT PHYSIOL & PHARMACOL,IL-69978 TEL AVIV,ISRAEL
[2] TEL AVIV UNIV,DR GEORGE S WISE CTR LIFE SCI,DEPT BIOCHEM,TEL AVIV,ISRAEL
关键词
acetylcholine release; autoantibodies; electromyography; Lambert‐Eaton myasthenic syndrome; Torpedo;
D O I
10.1002/mus.880130811
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lambert‐Eaton myasthenic syndrome (LEMS) is an autoimmune disorder characterized by reduced acetylcholine release at the neuromuscular junction. We report a model of the disease developed by active immunization of rats with purely cholinergic nerve terminals (synaptosomes) isolated from the Torpedo electric organ. Electromyographic studies of neuromuscular transmission in these rats showed a weak initial response followed by a pronounced incremental response to paired supramaximal stimuli (8 msec apart). There was no such response in control rats. There was no evidence of a postsynaptic transmission deficit in the synaptosomes immunized rats. We conclude that immunizing rats with Torpedo cholinergic nerve terminals causes a specific presynaptic dysfunction and may serve as a model for the study of LEMS. Copyright © 1990 John Wiley & Sons, Inc.
引用
收藏
页码:726 / 733
页数:8
相关论文
共 50 条
  • [21] Management/Treatment of Lambert-Eaton Myasthenic Syndrome
    Harada, Yohei
    Guptill, Jeffrey T.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2021, 23 (10)
  • [22] Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions
    Honnorat, Jerome
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2014, 198 (02): : 243 - 254
  • [23] Italian recommendations for Lambert-Eaton myasthenic syndrome (LEMS) management
    Evoli, A.
    Liguori, R.
    Romani, A.
    Mantegazza, R.
    Di Muzio, A.
    Giometto, B.
    Pegoraro, E.
    Rodolico, C.
    Vigliani, M. C.
    NEUROLOGICAL SCIENCES, 2014, 35 (04) : 515 - 520
  • [24] Update in the Management of Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome
    Bodkin, Cynthia
    Pascuzzi, Robert M.
    NEUROLOGIC CLINICS, 2021, 39 (01) : 133 - 146
  • [25] "DROPPED HEAD SYNDROME" CAUSED BY LAMBERT-EATON MYASTHENIC SYNDROME
    Ueda, T.
    Kanda, F.
    Kobessho, H.
    Hamaguchi, H.
    Motomura, M.
    MUSCLE & NERVE, 2009, 40 (01) : 134 - 136
  • [26] Tubular aggregates in autoimmune Lambert-Eaton myasthenic syndrome
    Cordts, Isabell
    Funk, Fabian
    Schulz, Joerg B.
    Weis, Joachim
    Claeys, Kristl G.
    NEUROMUSCULAR DISORDERS, 2016, 26 (12) : 880 - 884
  • [27] Lambert-Eaton myasthenic syndrome as an autoimmune calcium channelopathy
    Takamori, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 322 (04) : 1347 - 1351
  • [28] AN IMPROVED DIAGNOSTIC ASSAY FOR LAMBERT-EATON MYASTHENIC SYNDROME
    MOTOMURA, M
    JOHNSTON, I
    LANG, B
    VINCENT, A
    NEWSOMDAVIS, J
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 58 (01) : 85 - 87
  • [29] Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome
    Tyler B. Tarr
    Peter Wipf
    Stephen D. Meriney
    Molecular Neurobiology, 2015, 52 : 456 - 463
  • [30] Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome
    Tarr, Tyler B.
    Wipf, Peter
    Meriney, Stephen D.
    MOLECULAR NEUROBIOLOGY, 2015, 52 (01) : 456 - 463